Kyowa Pharma Chemical Co Ltd, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is TRANEXAMIC ACID DRUG SUBSTANCE, with a corresponding US DMF Number 26128.
Remarkably, this DMF maintains an Active status since its submission on June 05, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 27, 2016, and payment made on May 23, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II